spacer
home > pmps > summer 2002 > the polish pharmaceutical industry - dynamic growth in a challenging legal environment
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Polish Pharmaceutical Industry - Dynamic Growth in a Challenging Legal Environment

The Polish pharmaceutical industry has undergone tremendous change during the 12 years of the economical and political transformation that has taken place since the fall of communism. The privatisation of the state-owned pharmaceutical producers and the fast-changing legal environment - particularly influenced by the ongoing accession negotiations with the European Union - form the landscape in which Polish and foreign producers currently operate.

Dynamic Growth

The Polish pharmaceutical market has been growing notably in the last few years. Sales of pharmaceuticals have risen from approximately US$500 million to US$2,500 million in 2001, with the year-on-year growth of sales recorded in 2001 equal to 17 per cent. Some forecasts envisage the pharmaceutical market equaling US$4,500 million in 2005.

The Polish market is characterised by fairly large unit sales per inhabitant (34 per inhabitant compared with 27 in Italy), but a relatively low value of each sale (approximately US$1.6 per sale compared with US$4.9 in France). Given the fact the typical Pole is fairly interested in his/her health, it can be expected that the value of each sale will rise in the future as the society becomes more affluent. There are approximately 200 pharmaceutical firms active in Poland, most of them relatively small, and overall employing around 20,000 people.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Wladyslaw Rzycki, Attorney at White & Case Wladyslaw Rzycki is a US and Polish Lawyer with experience in many tax, commercial and financial transactions in the US, including structuring and planning for multinationals, pharmaceutical companies, e-commerce companies and venture capital investment offshore.
Prior to joining White & Case in June 2001, Wladyslaw worked at the law firm Mayer, Brown & Platt in Chicago where his practice focused on mergers and acquisitions corporate taxation, international taxation and taxation of financial instruments.

spacer
Wladyslaw Rzycki
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

Time lapse photography to demonstrate the potential antimicrobial abilities of Dycem contamination control flooring

Dycem

A defined volume of bioluminescent reporter bacteria was deposited onto 20 mm x 20 mm coupons of Dycem flooring, vinyl tile and ITW Alma tacky mat. Through monitoring of bacterial bioluminescence, metabolic inhibition was observed on all three surfaces however the effect occurred more rapidly on Dycem flooring than on vinyl or ITW Alma. Recovery counts after three hours of exposure to the floor surfaces showed between a 65% and 100% decrease in the number of viable organisms recovered from Dycem flooring compared to controls. On vinyl and ITW Alma flooring, there were slight increases in the number of viable survivors recovered compared to controls. Dycem flooring inhibited the metabolic activity and reduced the number of viable survivors recovered of Salmonella enterica Serovar Typhimurium DT104 pGLITE. It remains unclear as to whether this effect is attributable to the impregnated biocide or rapid drying of the inoculum on this surface.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement